| | | | | | | |
 | ZOETIS | 3.22% | 9.94% | -28.45% | -6.74% | 54.45% | 82 176 |
| ELANCO ANIMAL HEALTH INCORPORATED | 3.36% | 0.29% | -27.38% | -41.18% | -39.90% | 9 771 |
 | DECHRA PHARMACEUTICALS PLC | 2.30% | 8.28% | -34.14% | -19.08% | 28.93% | 4 567 |
 | BLUESTAR ADISSEO COMPANY | 1.15% | -1.52% | -21.27% | -21.52% | -8.40% | 3 889 |
 | VIRBAC | 0.28% | 6.49% | -14.72% | 27.46% | 115.48% | 3 217 |
 | VIMIAN GROUP AB (PUBL) | 3.96% | 14.99% | -33.77% | -43.37% | --.--% | 1 943 |
| CHINA ANIMAL HUSBANDRY INDUSTRY CO., LTD. | 0.39% | -3.42% | -2.75% | 5.65% | 58.73% | 1 930 |
| WUHAN KEQIAN BIOLOGY CO.,LTD | 0.44% | 0.04% | -1.45% | -23.06% | --.--% | 1 886 |
| JINYU BIO-TECHNOLOGY CO., LTD. | -0.76% | -1.20% | -44.40% | -48.18% | -42.79% | 1 520 |
| SWEDENCARE AB (PUBL) | 3.98% | 3.48% | -41.27% | -10.69% | 510.68% | 1 357 |
| TIANJIN RINGPU BIO-TECHNOLOGY CO.,LTD. | 0.40% | -0.90% | -27.36% | -49.10% | 53.82% | 1 215 |
| PULIKE BIOLOGICAL ENGINEERING, INC. | -6.31% | -7.03% | 13.62% | 6.35% | 103.98% | 1 181 |
| SHANGHAI HILE BIO-TECHNOLOGY CO., LTD. | 0.34% | 0.87% | -23.92% | -20.27% | -18.26% | 1 121 |
| PHIBRO ANIMAL HEALTH CORPORATION | 7.07% | 11.78% | -0.59% | -28.65% | -35.33% | 822 |
| HVSEN BIOTECHNOLOGY CO., LTD. | -0.44% | 2.97% | -13.45% | -37.33% | --.--% | 612 |
| | | | | | | |
| | Moyenne | 1.29% | 3.00% | -20.09% | -20.65% | 65.12% | |
| | Moyenne pondérée par Capi. | 2.78% | 7.69% | -26.80% | -11.64% | 48.21% | |
English (USA)
English (UK)
English (Canada)
Deutsch (Deutschland)
Deutsch (Schweiz)
Español
Italiano
Nederlands (Nederland)
Nederlands (België)
bourse
Rapport
